Viva BioInnovator
Overview
Viva BioInnovator is the specialized investment and incubation arm of Viva Biotech.
Investment Focus
- Innovative biotech ideas with transformative potential
- Early-stage biotech startups seeking investment and incubation support
- Founders aiming for clinical success in the biotech industry
Portfolio Companies
Get the full list of 54,000+ investors
Viva BioInnovator and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Viva BioInnovator
What sectors does Viva BioInnovator invest in?
Viva BioInnovator invests in Healthcare and Biotechnology, and is based in Shanghai, China. Viva BioInnovator is listed as a vc in the ConnectSafely investor database.
What stage does Viva BioInnovator invest at?
Viva BioInnovator backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does Viva BioInnovator invest in?
Viva BioInnovator invests across United States, Canada, Europe and China.
Who are the partners at Viva BioInnovator?
Team members listed for Viva BioInnovator include Guanghui Hu (Venture Partner) and Cheney Mao (Founder, Chairman, CEO).
What companies has Viva BioInnovator invested in?
Viva BioInnovator's portfolio includes ArrePath, Reglagene, i2O Therapeutics, Karma Biotechnologies, Tatara Therapeutics, Full Circles, Amberstone Biosciences and Exarta Therapeutics.
How do I contact Viva BioInnovator?
Viva BioInnovator's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
